2004 - Joseph Zubin Award, American Psychopathological Association
His primary areas of study are Psychiatry, Depression, Clinical psychology, Internal medicine and Executive dysfunction. He has researched Psychiatry in several fields, including Dementia and Public health. The various areas that George S. Alexopoulos examines in his Depression study include Age of onset and Comorbidity.
The concepts of his Clinical psychology study are interwoven with issues in Psychomotor retardation, Depression of Alzheimer disease and Rating scale. His Internal medicine research integrates issues from Placebo and Cardiology. His Executive dysfunction study incorporates themes from Vigilance, Stroop effect, Supportive psychotherapy, Executive functions and Perseveration.
His primary areas of investigation include Psychiatry, Depression, Clinical psychology, Internal medicine and Late life depression. His Psychiatry research is multidisciplinary, incorporating perspectives in Randomized controlled trial and Dementia. His research in Depression focuses on subjects like Physical therapy, which are connected to COPD.
The Clinical psychology study combines topics in areas such as Perseveration and Rating scale. His work carried out in the field of Internal medicine brings together such families of science as White matter, Endocrinology, Cardiology, Placebo and Nortriptyline. His Late life depression study frequently links to other fields, such as Apathy.
His main research concerns Depression, Late life depression, Psychiatry, Psychotic depression and Randomized controlled trial. His research on Depression focuses in particular on Major depressive disorder. His Late life depression research includes themes of Rating scale, Reward system, Anterior cingulate cortex, Clinical psychology and Referral.
His study in Dementia extends to Psychiatry with its themes. His Psychotic depression study combines topics in areas such as Pharmacotherapy, Antipsychotic and Sertraline. His studies in Randomized controlled trial integrate themes in fields like Antidepressant and Double blind.
George S. Alexopoulos mainly investigates Depression, Randomized controlled trial, Late life depression, Psychological intervention and Clinical psychology. His work in the fields of Problem solving therapy overlaps with other areas such as Mixed effects. His Randomized controlled trial study also includes
In Late life depression, George S. Alexopoulos works on issues like Executive functions, which are connected to Cohort, Disease, Effects of sleep deprivation on cognitive performance, Anterior cingulate cortex and Memory span. His Clinical psychology research includes elements of Insomnia, Neuropsychological assessment, Apathy, Cognition and Behavioral activation. George S. Alexopoulos works mostly in the field of Cognitive remediation therapy, limiting it down to topics relating to Neuroplasticity and, in certain cases, Antidepressant.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cornell Scale for Depression in Dementia.
George S. Alexopoulos;Robert C. Abrams;Robert C. Young;Charles A. Shamoian.
Biological Psychiatry (1988)
'Vascular depression' hypothesis.
George S. Alexopoulos;Barnett S. Meyers;Robert C. Young;Scott Campbell.
Archives of General Psychiatry (1997)
Depression in the elderly
George S Alexopoulos.
The Lancet (2005)
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
Andrew T Drysdale;Logan Grosenick;Logan Grosenick;Jonathan Downar;Katharine Dunlop.
Nature Medicine (2017)
Diagnosis and Treatment of Depression in Late Life: Consensus Statement Update
Barry D. Lebowitz;Jane L. Pearson;Lon S. Schneider;Charles F. Reynolds.
JAMA (1997)
Reducing Suicidal Ideation and Depressive Symptoms in Depressed Older Primary Care Patients: A Randomized Controlled Trial
Martha L. Bruce;Thomas R. Ten Have;Charles F. Reynolds;Ira I. Katz.
JAMA (2004)
Perceived Stigma as a Predictor of Treatment Discontinuation in Young and Older Outpatients With Depression
Jo Anne Sirey;Martha L. Bruce;George S. Alexopoulos;Deborah A. Perlick.
American Journal of Psychiatry (2001)
Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence.
Jo Anne Sirey;Martha L. Bruce;George S. Alexopoulos;Deborah A. Perlick.
Psychiatric Services (2001)
The vascular depression hypothesis: mechanisms linking vascular disease with depression.
Warren D. Taylor;Howard J. Aizenstein;George S. Alexopoulos.
Molecular Psychiatry (2013)
Consensus Statement on the Upcoming Crisis in Geriatric Mental Health: Research Agenda for the Next 2 Decades
Dilip V. Jeste;George S. Alexopoulos;Stephen J. Bartels;Jeffrey L. Cummings.
Archives of General Psychiatry (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Cornell University
Nathan Kline Institute for Psychiatric Research
Centre for Addiction and Mental Health
Dartmouth College
University of Pittsburgh
University of Washington
University of Toronto
University of Minnesota
Centre for Addiction and Mental Health
Cornell University
University of Maryland, College Park
University of Tennessee at Knoxville
Pennsylvania State University
Ankara University
University of Alabama
Gifu Pharmaceutical University
Pennsylvania State University
University of Illinois at Chicago
United States Department of the Army
Swansea University
Smithsonian Environmental Research Center
University of Oviedo
Innovation Research and Training
University of Hawaii at Manoa
Wake Forest University
Brigham and Women's Hospital